Medical Care
Global Nuclear Medicine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 06, 25
- ID: 291813
- Pages: 144
- Figures: 137
- Views: 5
In 2024, the global market size of Nuclear Medicine was estimated to be worth US$ 6875 million and is forecast to reach approximately US$ 11090 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.
Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.
The Nuclear Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Yantai Dongcheng
Segment by Type
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Segment by Application
Oncology
Thyroid
Cardiology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Nuclear Medicine in global and regional level.
Chapter 3: Detailed analysis of Nuclear Medicine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Medicine revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.
Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.
The Nuclear Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Yantai Dongcheng
Segment by Type
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Segment by Application
Oncology
Thyroid
Cardiology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Nuclear Medicine in global and regional level.
Chapter 3: Detailed analysis of Nuclear Medicine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Medicine revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Nuclear Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Diagnostic Nuclear Medicine
1.2.3 Therapeutic Nuclear Medicine
1.3 Market by Application
1.3.1 Global Nuclear Medicine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nuclear Medicine Market Size Estimates and Forecasts
2.2 Nuclear Medicine Market Size by Region: 2024 Versus 2031
2.2.1 Global Nuclear Medicine Revenue by Region: 2020-2025
2.2.2 Global Nuclear Medicine Revenue Forecast by Region (2026-2031)
2.2.3 Global Nuclear Medicine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Nuclear Medicine Revenue by Type (2020-2031)
3.1.2 Global Nuclear Medicine Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Nuclear Medicine Revenue by Application (2020-2031)
3.2.2 Global Nuclear Medicine Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Diagnostic Nuclear Medicine of Nuclear Medicine Revenue Market Share by Application
3.3.2 Therapeutic Nuclear Medicine of Nuclear Medicine Revenue Market Share by Application
4 Global Nuclear Medicine by Company
4.1 Global Nuclear Medicine Revenue by Company (2020-2025)
4.2 Global Nuclear Medicine Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Nuclear Medicine Companies around the World: Ranking by Revenue
4.3.2 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Nuclear Medicine Companies Headquarters & Product Type
4.4.1 Global Nuclear Medicine Companies Headquarters
4.4.2 Date of International Companies Enter into Nuclear Medicine Market
4.4.3 Global Nuclear Medicine Companies Product & Service
4.4.4 Diagnostic Nuclear Medicine Revenue Market Share of Nuclear Medicine by Company
4.4.5 Therapeutic Nuclear Medicine Revenue Market Share of Nuclear Medicine by Company
4.5 Global Nuclear Medicine Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Cardinal Health
5.1.1 Cardinal Health Corporation Information
5.1.2 Cardinal Health Description, Business Overview
5.1.3 Cardinal Health Nuclear Medicine Products Offered
5.1.4 Cardinal Health Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.1.5 Cardinal Health Nuclear Medicine Revenue by Product in 2024
5.1.6 Cardinal Health Nuclear Medicine Revenue by Application in 2024
5.1.7 Cardinal Health Nuclear Medicine Revenue by Geographic Area in 2024
5.1.8 Cardinal Health Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Corporation Information
5.2.2 GE Healthcare Description, Business Overview
5.2.3 GE Healthcare Nuclear Medicine Products Offered
5.2.4 GE Healthcare Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.2.5 GE Healthcare Nuclear Medicine Revenue by Product in 2024
5.2.6 GE Healthcare Nuclear Medicine Revenue by Application in 2024
5.2.7 GE Healthcare Nuclear Medicine Revenue by Geographic Area in 2024
5.2.8 GE Healthcare Recent Developments
5.3 Jubilant Pharma
5.3.1 Jubilant Pharma Corporation Information
5.3.2 Jubilant Pharma Description, Business Overview
5.3.3 Jubilant Pharma Nuclear Medicine Products Offered
5.3.4 Jubilant Pharma Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.3.5 Jubilant Pharma Nuclear Medicine Revenue by Product in 2024
5.3.6 Jubilant Pharma Nuclear Medicine Revenue by Application in 2024
5.3.7 Jubilant Pharma Nuclear Medicine Revenue by Geographic Area in 2024
5.3.8 Jubilant Pharma Recent Developments
5.4 Novartis
5.4.1 Novartis Corporation Information
5.4.2 Novartis Description, Business Overview
5.4.3 Novartis Nuclear Medicine Products Offered
5.4.4 Novartis Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.4.5 Novartis Nuclear Medicine Revenue by Product in 2024
5.4.6 Novartis Nuclear Medicine Revenue by Application in 2024
5.4.7 Novartis Nuclear Medicine Revenue by Geographic Area in 2024
5.4.8 Novartis Recent Developments
5.5 Curium Pharma
5.5.1 Curium Pharma Corporation Information
5.5.2 Curium Pharma Description, Business Overview
5.5.3 Curium Pharma Nuclear Medicine Products Offered
5.5.4 Curium Pharma Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.5.5 Curium Pharma Nuclear Medicine Revenue by Product in 2024
5.5.6 Curium Pharma Nuclear Medicine Revenue by Application in 2024
5.5.7 Curium Pharma Nuclear Medicine Revenue by Geographic Area in 2024
5.5.8 Curium Pharma Recent Developments
5.6 SIEMENS
5.6.1 SIEMENS Corporation Information
5.6.2 SIEMENS Description, Business Overview
5.6.3 SIEMENS Nuclear Medicine Products Offered
5.6.4 SIEMENS Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.6.5 SIEMENS Nuclear Medicine Revenue by Product in 2024
5.6.6 SIEMENS Nuclear Medicine Revenue by Application in 2024
5.6.7 SIEMENS Nuclear Medicine Revenue by Geographic Area in 2024
5.6.8 SIEMENS Recent Developments
5.7 Lantheus
5.7.1 Lantheus Corporation Information
5.7.2 Lantheus Description, Business Overview
5.7.3 Lantheus Nuclear Medicine Products Offered
5.7.4 Lantheus Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.7.5 Lantheus Nuclear Medicine Revenue by Product in 2024
5.7.6 Lantheus Nuclear Medicine Revenue by Application in 2024
5.7.7 Lantheus Nuclear Medicine Revenue by Geographic Area in 2024
5.7.8 Lantheus Recent Developments
5.8 Bracco Imaging
5.8.1 Bracco Imaging Corporation Information
5.8.2 Bracco Imaging Description, Business Overview
5.8.3 Bracco Imaging Nuclear Medicine Products Offered
5.8.4 Bracco Imaging Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.8.5 Bracco Imaging Nuclear Medicine Revenue by Product in 2024
5.8.6 Bracco Imaging Nuclear Medicine Revenue by Application in 2024
5.8.7 Bracco Imaging Nuclear Medicine Revenue by Geographic Area in 2024
5.8.8 Bracco Imaging Recent Developments
5.9 Bayer
5.9.1 Bayer Corporation Information
5.9.2 Bayer Description, Business Overview
5.9.3 Bayer Nuclear Medicine Products Offered
5.9.4 Bayer Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.9.5 Bayer Nuclear Medicine Revenue by Product in 2024
5.9.6 Bayer Nuclear Medicine Revenue by Application in 2024
5.9.7 Bayer Nuclear Medicine Revenue by Geographic Area in 2024
5.9.8 Bayer Recent Developments
5.10 Eli Lilly
5.10.1 Eli Lilly Corporation Information
5.10.2 Eli Lilly Description, Business Overview
5.10.3 Eli Lilly Nuclear Medicine Products Offered
5.10.4 Eli Lilly Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.10.5 Eli Lilly Nuclear Medicine Revenue by Product in 2024
5.10.6 Eli Lilly Nuclear Medicine Revenue by Application in 2024
5.10.7 Eli Lilly Nuclear Medicine Revenue by Geographic Area in 2024
5.10.8 Eli Lilly Recent Developments
5.11 Aurobindo Pharma
5.11.1 Aurobindo Pharma Corporation Information
5.11.2 Aurobindo Pharma Description, Business Overview
5.11.3 Aurobindo Pharma Nuclear Medicine Products Offered
5.11.4 Aurobindo Pharma Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.11.5 Aurobindo Pharma Nuclear Medicine Revenue by Product in 2024
5.11.6 Aurobindo Pharma Nuclear Medicine Revenue by Application in 2024
5.11.7 Aurobindo Pharma Nuclear Medicine Revenue by Geographic Area in 2024
5.11.8 Aurobindo Pharma Recent Developments
5.12 Mundipharma
5.12.1 Mundipharma Corporation Information
5.12.2 Mundipharma Description, Business Overview
5.12.3 Mundipharma Nuclear Medicine Products Offered
5.12.4 Mundipharma Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.12.5 Mundipharma Nuclear Medicine Revenue by Product in 2024
5.12.6 Mundipharma Nuclear Medicine Revenue by Application in 2024
5.12.7 Mundipharma Nuclear Medicine Revenue by Geographic Area in 2024
5.12.8 Mundipharma Recent Developments
5.13 China Isotope & Radiation
5.13.1 China Isotope & Radiation Corporation Information
5.13.2 China Isotope & Radiation Description, Business Overview
5.13.3 China Isotope & Radiation Nuclear Medicine Products Offered
5.13.4 China Isotope & Radiation Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.13.5 China Isotope & Radiation Nuclear Medicine Revenue by Product in 2024
5.13.6 China Isotope & Radiation Nuclear Medicine Revenue by Application in 2024
5.13.7 China Isotope & Radiation Nuclear Medicine Revenue by Geographic Area in 2024
5.13.8 China Isotope & Radiation Recent Developments
5.14 Yantai Dongcheng
5.14.1 Yantai Dongcheng Corporation Information
5.14.2 Yantai Dongcheng Description, Business Overview
5.14.3 Yantai Dongcheng Nuclear Medicine Products Offered
5.14.4 Yantai Dongcheng Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.14.5 Yantai Dongcheng Nuclear Medicine Revenue by Product in 2024
5.14.6 Yantai Dongcheng Nuclear Medicine Revenue by Application in 2024
5.14.7 Yantai Dongcheng Nuclear Medicine Revenue by Geographic Area in 2024
5.14.8 Yantai Dongcheng Recent Developments
6 North America
6.1 North America Nuclear Medicine Market Size YoY Growth 2020-2031
6.2 North America Nuclear Medicine Market Facts & Figures by Country (2020-2031)
6.3 North America Nuclear Medicine Revenue by Type (2020-2025)
6.4 North America Nuclear Medicine Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Nuclear Medicine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Nuclear Medicine Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Nuclear Medicine Revenue by Type (2020-2025)
7.4 Asia-Pacific Nuclear Medicine Revenue by Application (2020-2025)
8 Europe
8.1 Europe Nuclear Medicine Market Size YoY Growth 2020-2031
8.2 Europe Nuclear Medicine Market Facts & Figures by Country (2020-2031)
8.3 Europe Nuclear Medicine Revenue by Type (2020-2025)
8.4 Europe Nuclear Medicine Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Nuclear Medicine Market Size YoY Growth 2020-2031
9.2 Latin America Nuclear Medicine Market Facts & Figures by Country (2020-2031)
9.3 Latin America Nuclear Medicine Revenue by Type (2020-2025)
9.4 Latin America Nuclear Medicine Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Nuclear Medicine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Nuclear Medicine Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Nuclear Medicine Revenue by Type (2020-2025)
10.4 Middle East and Africa Nuclear Medicine Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Nuclear Medicine Supply Chain Analysis
11.2 Nuclear Medicine Key Raw Materials and Upstream Suppliers
11.3 Nuclear Medicine Clients Analysis
11.4 Nuclear Medicine Sales Channel and Sales Model Analysis
11.4.1 Nuclear Medicine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Nuclear Medicine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Nuclear Medicine Distributors
12 Nuclear Medicine Market Dynamics
12.1 Nuclear Medicine Industry Trends
12.2 Nuclear Medicine Market Drivers
12.3 Nuclear Medicine Market Challenges
12.4 Nuclear Medicine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Nuclear Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Diagnostic Nuclear Medicine
1.2.3 Therapeutic Nuclear Medicine
1.3 Market by Application
1.3.1 Global Nuclear Medicine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nuclear Medicine Market Size Estimates and Forecasts
2.2 Nuclear Medicine Market Size by Region: 2024 Versus 2031
2.2.1 Global Nuclear Medicine Revenue by Region: 2020-2025
2.2.2 Global Nuclear Medicine Revenue Forecast by Region (2026-2031)
2.2.3 Global Nuclear Medicine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Nuclear Medicine Revenue by Type (2020-2031)
3.1.2 Global Nuclear Medicine Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Nuclear Medicine Revenue by Application (2020-2031)
3.2.2 Global Nuclear Medicine Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Diagnostic Nuclear Medicine of Nuclear Medicine Revenue Market Share by Application
3.3.2 Therapeutic Nuclear Medicine of Nuclear Medicine Revenue Market Share by Application
4 Global Nuclear Medicine by Company
4.1 Global Nuclear Medicine Revenue by Company (2020-2025)
4.2 Global Nuclear Medicine Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Nuclear Medicine Companies around the World: Ranking by Revenue
4.3.2 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Nuclear Medicine Companies Headquarters & Product Type
4.4.1 Global Nuclear Medicine Companies Headquarters
4.4.2 Date of International Companies Enter into Nuclear Medicine Market
4.4.3 Global Nuclear Medicine Companies Product & Service
4.4.4 Diagnostic Nuclear Medicine Revenue Market Share of Nuclear Medicine by Company
4.4.5 Therapeutic Nuclear Medicine Revenue Market Share of Nuclear Medicine by Company
4.5 Global Nuclear Medicine Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Cardinal Health
5.1.1 Cardinal Health Corporation Information
5.1.2 Cardinal Health Description, Business Overview
5.1.3 Cardinal Health Nuclear Medicine Products Offered
5.1.4 Cardinal Health Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.1.5 Cardinal Health Nuclear Medicine Revenue by Product in 2024
5.1.6 Cardinal Health Nuclear Medicine Revenue by Application in 2024
5.1.7 Cardinal Health Nuclear Medicine Revenue by Geographic Area in 2024
5.1.8 Cardinal Health Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Corporation Information
5.2.2 GE Healthcare Description, Business Overview
5.2.3 GE Healthcare Nuclear Medicine Products Offered
5.2.4 GE Healthcare Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.2.5 GE Healthcare Nuclear Medicine Revenue by Product in 2024
5.2.6 GE Healthcare Nuclear Medicine Revenue by Application in 2024
5.2.7 GE Healthcare Nuclear Medicine Revenue by Geographic Area in 2024
5.2.8 GE Healthcare Recent Developments
5.3 Jubilant Pharma
5.3.1 Jubilant Pharma Corporation Information
5.3.2 Jubilant Pharma Description, Business Overview
5.3.3 Jubilant Pharma Nuclear Medicine Products Offered
5.3.4 Jubilant Pharma Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.3.5 Jubilant Pharma Nuclear Medicine Revenue by Product in 2024
5.3.6 Jubilant Pharma Nuclear Medicine Revenue by Application in 2024
5.3.7 Jubilant Pharma Nuclear Medicine Revenue by Geographic Area in 2024
5.3.8 Jubilant Pharma Recent Developments
5.4 Novartis
5.4.1 Novartis Corporation Information
5.4.2 Novartis Description, Business Overview
5.4.3 Novartis Nuclear Medicine Products Offered
5.4.4 Novartis Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.4.5 Novartis Nuclear Medicine Revenue by Product in 2024
5.4.6 Novartis Nuclear Medicine Revenue by Application in 2024
5.4.7 Novartis Nuclear Medicine Revenue by Geographic Area in 2024
5.4.8 Novartis Recent Developments
5.5 Curium Pharma
5.5.1 Curium Pharma Corporation Information
5.5.2 Curium Pharma Description, Business Overview
5.5.3 Curium Pharma Nuclear Medicine Products Offered
5.5.4 Curium Pharma Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.5.5 Curium Pharma Nuclear Medicine Revenue by Product in 2024
5.5.6 Curium Pharma Nuclear Medicine Revenue by Application in 2024
5.5.7 Curium Pharma Nuclear Medicine Revenue by Geographic Area in 2024
5.5.8 Curium Pharma Recent Developments
5.6 SIEMENS
5.6.1 SIEMENS Corporation Information
5.6.2 SIEMENS Description, Business Overview
5.6.3 SIEMENS Nuclear Medicine Products Offered
5.6.4 SIEMENS Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.6.5 SIEMENS Nuclear Medicine Revenue by Product in 2024
5.6.6 SIEMENS Nuclear Medicine Revenue by Application in 2024
5.6.7 SIEMENS Nuclear Medicine Revenue by Geographic Area in 2024
5.6.8 SIEMENS Recent Developments
5.7 Lantheus
5.7.1 Lantheus Corporation Information
5.7.2 Lantheus Description, Business Overview
5.7.3 Lantheus Nuclear Medicine Products Offered
5.7.4 Lantheus Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.7.5 Lantheus Nuclear Medicine Revenue by Product in 2024
5.7.6 Lantheus Nuclear Medicine Revenue by Application in 2024
5.7.7 Lantheus Nuclear Medicine Revenue by Geographic Area in 2024
5.7.8 Lantheus Recent Developments
5.8 Bracco Imaging
5.8.1 Bracco Imaging Corporation Information
5.8.2 Bracco Imaging Description, Business Overview
5.8.3 Bracco Imaging Nuclear Medicine Products Offered
5.8.4 Bracco Imaging Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.8.5 Bracco Imaging Nuclear Medicine Revenue by Product in 2024
5.8.6 Bracco Imaging Nuclear Medicine Revenue by Application in 2024
5.8.7 Bracco Imaging Nuclear Medicine Revenue by Geographic Area in 2024
5.8.8 Bracco Imaging Recent Developments
5.9 Bayer
5.9.1 Bayer Corporation Information
5.9.2 Bayer Description, Business Overview
5.9.3 Bayer Nuclear Medicine Products Offered
5.9.4 Bayer Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.9.5 Bayer Nuclear Medicine Revenue by Product in 2024
5.9.6 Bayer Nuclear Medicine Revenue by Application in 2024
5.9.7 Bayer Nuclear Medicine Revenue by Geographic Area in 2024
5.9.8 Bayer Recent Developments
5.10 Eli Lilly
5.10.1 Eli Lilly Corporation Information
5.10.2 Eli Lilly Description, Business Overview
5.10.3 Eli Lilly Nuclear Medicine Products Offered
5.10.4 Eli Lilly Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.10.5 Eli Lilly Nuclear Medicine Revenue by Product in 2024
5.10.6 Eli Lilly Nuclear Medicine Revenue by Application in 2024
5.10.7 Eli Lilly Nuclear Medicine Revenue by Geographic Area in 2024
5.10.8 Eli Lilly Recent Developments
5.11 Aurobindo Pharma
5.11.1 Aurobindo Pharma Corporation Information
5.11.2 Aurobindo Pharma Description, Business Overview
5.11.3 Aurobindo Pharma Nuclear Medicine Products Offered
5.11.4 Aurobindo Pharma Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.11.5 Aurobindo Pharma Nuclear Medicine Revenue by Product in 2024
5.11.6 Aurobindo Pharma Nuclear Medicine Revenue by Application in 2024
5.11.7 Aurobindo Pharma Nuclear Medicine Revenue by Geographic Area in 2024
5.11.8 Aurobindo Pharma Recent Developments
5.12 Mundipharma
5.12.1 Mundipharma Corporation Information
5.12.2 Mundipharma Description, Business Overview
5.12.3 Mundipharma Nuclear Medicine Products Offered
5.12.4 Mundipharma Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.12.5 Mundipharma Nuclear Medicine Revenue by Product in 2024
5.12.6 Mundipharma Nuclear Medicine Revenue by Application in 2024
5.12.7 Mundipharma Nuclear Medicine Revenue by Geographic Area in 2024
5.12.8 Mundipharma Recent Developments
5.13 China Isotope & Radiation
5.13.1 China Isotope & Radiation Corporation Information
5.13.2 China Isotope & Radiation Description, Business Overview
5.13.3 China Isotope & Radiation Nuclear Medicine Products Offered
5.13.4 China Isotope & Radiation Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.13.5 China Isotope & Radiation Nuclear Medicine Revenue by Product in 2024
5.13.6 China Isotope & Radiation Nuclear Medicine Revenue by Application in 2024
5.13.7 China Isotope & Radiation Nuclear Medicine Revenue by Geographic Area in 2024
5.13.8 China Isotope & Radiation Recent Developments
5.14 Yantai Dongcheng
5.14.1 Yantai Dongcheng Corporation Information
5.14.2 Yantai Dongcheng Description, Business Overview
5.14.3 Yantai Dongcheng Nuclear Medicine Products Offered
5.14.4 Yantai Dongcheng Nuclear Medicine Revenue and Gross Margin (2020-2025)
5.14.5 Yantai Dongcheng Nuclear Medicine Revenue by Product in 2024
5.14.6 Yantai Dongcheng Nuclear Medicine Revenue by Application in 2024
5.14.7 Yantai Dongcheng Nuclear Medicine Revenue by Geographic Area in 2024
5.14.8 Yantai Dongcheng Recent Developments
6 North America
6.1 North America Nuclear Medicine Market Size YoY Growth 2020-2031
6.2 North America Nuclear Medicine Market Facts & Figures by Country (2020-2031)
6.3 North America Nuclear Medicine Revenue by Type (2020-2025)
6.4 North America Nuclear Medicine Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Nuclear Medicine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Nuclear Medicine Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Nuclear Medicine Revenue by Type (2020-2025)
7.4 Asia-Pacific Nuclear Medicine Revenue by Application (2020-2025)
8 Europe
8.1 Europe Nuclear Medicine Market Size YoY Growth 2020-2031
8.2 Europe Nuclear Medicine Market Facts & Figures by Country (2020-2031)
8.3 Europe Nuclear Medicine Revenue by Type (2020-2025)
8.4 Europe Nuclear Medicine Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Nuclear Medicine Market Size YoY Growth 2020-2031
9.2 Latin America Nuclear Medicine Market Facts & Figures by Country (2020-2031)
9.3 Latin America Nuclear Medicine Revenue by Type (2020-2025)
9.4 Latin America Nuclear Medicine Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Nuclear Medicine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Nuclear Medicine Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Nuclear Medicine Revenue by Type (2020-2025)
10.4 Middle East and Africa Nuclear Medicine Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Nuclear Medicine Supply Chain Analysis
11.2 Nuclear Medicine Key Raw Materials and Upstream Suppliers
11.3 Nuclear Medicine Clients Analysis
11.4 Nuclear Medicine Sales Channel and Sales Model Analysis
11.4.1 Nuclear Medicine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Nuclear Medicine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Nuclear Medicine Distributors
12 Nuclear Medicine Market Dynamics
12.1 Nuclear Medicine Industry Trends
12.2 Nuclear Medicine Market Drivers
12.3 Nuclear Medicine Market Challenges
12.4 Nuclear Medicine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Nuclear Medicine Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Nuclear Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Nuclear Medicine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Nuclear Medicine Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Nuclear Medicine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Nuclear Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Nuclear Medicine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Nuclear Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Nuclear Medicine Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Nuclear Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 11. Nuclear Medicine Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Nuclear Medicine Players by Revenue (US$ Million) in 2024
Table 13. Global Nuclear Medicine Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2024)
Table 15. Global Nuclear Medicine Companies Headquarters
Table 16. Date of International Companies Enter into Nuclear Medicine Market
Table 17. Global Nuclear Medicine Companies Product & Service
Table 18. Global Nuclear Medicine Mergers & Acquisitions, Expansion Plans
Table 19. Cardinal Health Corporation Information
Table 20. Cardinal Health Description and Business Overview
Table 21. Cardinal Health Nuclear Medicine Product
Table 22. Cardinal Health Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Cardinal Health Revenue Proportion of Nuclear Medicine by Product in 2024
Table 24. Cardinal Health Revenue Proportion of Nuclear Medicine by Application in 2024
Table 25. Cardinal Health Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 26. Cardinal Health Recent Developments
Table 27. GE Healthcare Corporation Information
Table 28. GE Healthcare Description and Business Overview
Table 29. GE Healthcare Nuclear Medicine Product
Table 30. GE Healthcare Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. GE Healthcare Revenue Proportion of Nuclear Medicine by Product in 2024
Table 32. GE Healthcare Revenue Proportion of Nuclear Medicine by Application in 2024
Table 33. GE Healthcare Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 34. GE Healthcare Recent Developments
Table 35. Jubilant Pharma Corporation Information
Table 36. Jubilant Pharma Description and Business Overview
Table 37. Jubilant Pharma Nuclear Medicine Product
Table 38. Jubilant Pharma Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Jubilant Pharma Revenue Proportion of Nuclear Medicine by Product in 2024
Table 40. Jubilant Pharma Revenue Proportion of Nuclear Medicine by Application in 2024
Table 41. Jubilant Pharma Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 42. Jubilant Pharma Recent Developments
Table 43. Novartis Corporation Information
Table 44. Novartis Description and Business Overview
Table 45. Novartis Nuclear Medicine Product
Table 46. Novartis Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Novartis Revenue Proportion of Nuclear Medicine by Product in 2024
Table 48. Novartis Revenue Proportion of Nuclear Medicine by Application in 2024
Table 49. Novartis Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 50. Novartis Recent Developments
Table 51. Curium Pharma Corporation Information
Table 52. Curium Pharma Description and Business Overview
Table 53. Curium Pharma Nuclear Medicine Product
Table 54. Curium Pharma Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Curium Pharma Revenue Proportion of Nuclear Medicine by Product in 2024
Table 56. Curium Pharma Revenue Proportion of Nuclear Medicine by Application in 2024
Table 57. Curium Pharma Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 58. Curium Pharma Recent Developments
Table 59. SIEMENS Corporation Information
Table 60. SIEMENS Description and Business Overview
Table 61. SIEMENS Nuclear Medicine Product
Table 62. SIEMENS Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. SIEMENS Revenue Proportion of Nuclear Medicine by Product in 2024
Table 64. SIEMENS Revenue Proportion of Nuclear Medicine by Application in 2024
Table 65. SIEMENS Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 66. SIEMENS Recent Developments
Table 67. Lantheus Corporation Information
Table 68. Lantheus Description and Business Overview
Table 69. Lantheus Nuclear Medicine Product
Table 70. Lantheus Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Lantheus Revenue Proportion of Nuclear Medicine by Product in 2024
Table 72. Lantheus Revenue Proportion of Nuclear Medicine by Application in 2024
Table 73. Lantheus Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 74. Lantheus Recent Developments
Table 75. Bracco Imaging Corporation Information
Table 76. Bracco Imaging Description and Business Overview
Table 77. Bracco Imaging Nuclear Medicine Product
Table 78. Bracco Imaging Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Bracco Imaging Revenue Proportion of Nuclear Medicine by Product in 2024
Table 80. Bracco Imaging Revenue Proportion of Nuclear Medicine by Application in 2024
Table 81. Bracco Imaging Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 82. Bracco Imaging Recent Developments
Table 83. Bayer Corporation Information
Table 84. Bayer Description and Business Overview
Table 85. Bayer Nuclear Medicine Product
Table 86. Bayer Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Bayer Revenue Proportion of Nuclear Medicine by Product in 2024
Table 88. Bayer Revenue Proportion of Nuclear Medicine by Application in 2024
Table 89. Bayer Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 90. Bayer Recent Developments
Table 91. Eli Lilly Corporation Information
Table 92. Eli Lilly Description and Business Overview
Table 93. Eli Lilly Nuclear Medicine Product
Table 94. Eli Lilly Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Eli Lilly Revenue Proportion of Nuclear Medicine by Product in 2024
Table 96. Eli Lilly Revenue Proportion of Nuclear Medicine by Application in 2024
Table 97. Eli Lilly Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 98. Eli Lilly Recent Developments
Table 99. Aurobindo Pharma Corporation Information
Table 100. Aurobindo Pharma Description and Business Overview
Table 101. Aurobindo Pharma Nuclear Medicine Product
Table 102. Aurobindo Pharma Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Aurobindo Pharma Revenue Proportion of Nuclear Medicine by Product in 2024
Table 104. Aurobindo Pharma Revenue Proportion of Nuclear Medicine by Application in 2024
Table 105. Aurobindo Pharma Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 106. Aurobindo Pharma Recent Developments
Table 107. Mundipharma Corporation Information
Table 108. Mundipharma Description and Business Overview
Table 109. Mundipharma Nuclear Medicine Product
Table 110. Mundipharma Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Mundipharma Revenue Proportion of Nuclear Medicine by Product in 2024
Table 112. Mundipharma Revenue Proportion of Nuclear Medicine by Application in 2024
Table 113. Mundipharma Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 114. Mundipharma Recent Developments
Table 115. China Isotope & Radiation Corporation Information
Table 116. China Isotope & Radiation Description and Business Overview
Table 117. China Isotope & Radiation Nuclear Medicine Product
Table 118. China Isotope & Radiation Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. China Isotope & Radiation Revenue Proportion of Nuclear Medicine by Product in 2024
Table 120. China Isotope & Radiation Revenue Proportion of Nuclear Medicine by Application in 2024
Table 121. China Isotope & Radiation Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 122. China Isotope & Radiation Recent Developments
Table 123. Yantai Dongcheng Corporation Information
Table 124. Yantai Dongcheng Description and Business Overview
Table 125. Yantai Dongcheng Nuclear Medicine Product
Table 126. Yantai Dongcheng Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Yantai Dongcheng Revenue Proportion of Nuclear Medicine by Product in 2024
Table 128. Yantai Dongcheng Revenue Proportion of Nuclear Medicine by Application in 2024
Table 129. Yantai Dongcheng Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 130. Yantai Dongcheng Recent Developments
Table 131. North America Nuclear Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 132. North America Nuclear Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 133. North America Nuclear Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 134. North America Nuclear Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 135. Asia-Pacific Nuclear Medicine Revenue by Region (2020-2025) & (US$ Million)
Table 136. Asia-Pacific Nuclear Medicine Revenue by Region (2026-2031) & (US$ Million)
Table 137. Asia-Pacific Nuclear Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 138. Asia-Pacific Nuclear Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 139. Europe Nuclear Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 140. Europe Nuclear Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 141. Europe Nuclear Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 142. Europe Nuclear Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 143. Latin America Nuclear Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 144. Latin America Nuclear Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 145. Latin America Nuclear Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 146. Latin America Nuclear Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 147. Middle East and Africa Nuclear Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 148. Middle East and Africa Nuclear Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 149. Middle East and Africa Nuclear Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 150. Middle East and Africa Nuclear Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 151. Nuclear Medicine Key Raw Materials, Industry Status and Trend
Table 152. Nuclear Medicine Key Raw Materials and Upstream Suppliers
Table 153. Nuclear Medicine Clients Status and Trend
Table 154. Nuclear Medicine Typical Clients
Table 155. Nuclear Medicine Distributors
Table 156. Nuclear Medicine Market Trends
Table 157. Nuclear Medicine Market Drivers
Table 158. Nuclear Medicine Market Challenges
Table 159. Nuclear Medicine Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Medicine Product Picture
Figure 2. Global Nuclear Medicine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Nuclear Medicine Revenue Market Share by Type in 2024 & 2031
Figure 4. Diagnostic Nuclear Medicine Product Picture
Figure 5. Therapeutic Nuclear Medicine Product Picture
Figure 6. Global Nuclear Medicine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Nuclear Medicine Revenue Market Share by Application in 2024 & 2031
Figure 8. Oncology
Figure 9. Thyroid
Figure 10. Cardiology
Figure 11. Others
Figure 12. Nuclear Medicine Report Years Considered
Figure 13. Global Nuclear Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Nuclear Medicine Market Size (2020-2031) & (US$ Million)
Figure 15. Global Nuclear Medicine Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Nuclear Medicine Revenue Market Share by Region (2020-2031)
Figure 17. Global Nuclear Medicine Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Nuclear Medicine Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Diagnostic Nuclear Medicine of Nuclear Medicine Revenue Market Share by Application, 2024 VS 2031
Figure 20. Therapeutic Nuclear Medicine of Nuclear Medicine Revenue Market Share by Application, 2024 VS 2031
Figure 21. Nuclear Medicine Revenue Share by Company (2024)
Figure 22. Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Diagnostic Nuclear Medicine Revenue Proportion by Company in 2024
Figure 24. Therapeutic Nuclear Medicine Revenue Proportion by Company in 2024
Figure 25. North America Nuclear Medicine Revenue 2020-2031 (US$ Million)
Figure 26. North America Nuclear Medicine Revenue Market Share by Type (2020-2025)
Figure 27. North America Nuclear Medicine Revenue Market Share by Application (2020-2025)
Figure 28. Asia-Pacific Nuclear Medicine Revenue 2020-2031 (US$ Million)
Figure 29. Asia-Pacific Nuclear Medicine Revenue Market Share by Region (2020-2031)
Figure 30. Asia-Pacific Nuclear Medicine Revenue Market Share by Type (2020-2025)
Figure 31. Asia-Pacific Nuclear Medicine Revenue Market Share by Application (2020-2025)
Figure 32. Europe Nuclear Medicine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 33. Europe Nuclear Medicine Revenue Market Share by Country (2020-2031)
Figure 34. Europe Nuclear Medicine Revenue Market Share by Type (2020-2025)
Figure 35. Europe Nuclear Medicine Revenue Market Share by Application (2020-2025)
Figure 36. Latin America Nuclear Medicine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Latin America Nuclear Medicine Revenue Market Share by Country (2020-2031)
Figure 38. Latin America Nuclear Medicine Revenue Market Share by Type (2020-2025)
Figure 39. Latin America Nuclear Medicine Revenue Market Share by Application (2020-2025)
Figure 40. Middle East and Africa Nuclear Medicine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Middle East and Africa Nuclear Medicine Revenue Market Share by Country (2020-2031)
Figure 42. Middle East and Africa Nuclear Medicine Revenue Market Share by Type (2020-2025)
Figure 43. Middle East and Africa Nuclear Medicine Revenue Market Share by Application (2020-2025)
Figure 44. Nuclear Medicine Supply Chain (Upstream and Downstream Market)
Figure 45. Global Production Market Share of Nuclear Medicine Raw Materials by Region in 2024
Figure 46. Nuclear Medicine Distribution Channels
Figure 47. Global Nuclear Medicine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 48. Global Nuclear Medicine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Table 1. Global Nuclear Medicine Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Nuclear Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Nuclear Medicine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Nuclear Medicine Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Nuclear Medicine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Nuclear Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Nuclear Medicine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Nuclear Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Nuclear Medicine Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Nuclear Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 11. Nuclear Medicine Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Nuclear Medicine Players by Revenue (US$ Million) in 2024
Table 13. Global Nuclear Medicine Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2024)
Table 15. Global Nuclear Medicine Companies Headquarters
Table 16. Date of International Companies Enter into Nuclear Medicine Market
Table 17. Global Nuclear Medicine Companies Product & Service
Table 18. Global Nuclear Medicine Mergers & Acquisitions, Expansion Plans
Table 19. Cardinal Health Corporation Information
Table 20. Cardinal Health Description and Business Overview
Table 21. Cardinal Health Nuclear Medicine Product
Table 22. Cardinal Health Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Cardinal Health Revenue Proportion of Nuclear Medicine by Product in 2024
Table 24. Cardinal Health Revenue Proportion of Nuclear Medicine by Application in 2024
Table 25. Cardinal Health Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 26. Cardinal Health Recent Developments
Table 27. GE Healthcare Corporation Information
Table 28. GE Healthcare Description and Business Overview
Table 29. GE Healthcare Nuclear Medicine Product
Table 30. GE Healthcare Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. GE Healthcare Revenue Proportion of Nuclear Medicine by Product in 2024
Table 32. GE Healthcare Revenue Proportion of Nuclear Medicine by Application in 2024
Table 33. GE Healthcare Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 34. GE Healthcare Recent Developments
Table 35. Jubilant Pharma Corporation Information
Table 36. Jubilant Pharma Description and Business Overview
Table 37. Jubilant Pharma Nuclear Medicine Product
Table 38. Jubilant Pharma Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Jubilant Pharma Revenue Proportion of Nuclear Medicine by Product in 2024
Table 40. Jubilant Pharma Revenue Proportion of Nuclear Medicine by Application in 2024
Table 41. Jubilant Pharma Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 42. Jubilant Pharma Recent Developments
Table 43. Novartis Corporation Information
Table 44. Novartis Description and Business Overview
Table 45. Novartis Nuclear Medicine Product
Table 46. Novartis Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Novartis Revenue Proportion of Nuclear Medicine by Product in 2024
Table 48. Novartis Revenue Proportion of Nuclear Medicine by Application in 2024
Table 49. Novartis Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 50. Novartis Recent Developments
Table 51. Curium Pharma Corporation Information
Table 52. Curium Pharma Description and Business Overview
Table 53. Curium Pharma Nuclear Medicine Product
Table 54. Curium Pharma Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Curium Pharma Revenue Proportion of Nuclear Medicine by Product in 2024
Table 56. Curium Pharma Revenue Proportion of Nuclear Medicine by Application in 2024
Table 57. Curium Pharma Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 58. Curium Pharma Recent Developments
Table 59. SIEMENS Corporation Information
Table 60. SIEMENS Description and Business Overview
Table 61. SIEMENS Nuclear Medicine Product
Table 62. SIEMENS Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. SIEMENS Revenue Proportion of Nuclear Medicine by Product in 2024
Table 64. SIEMENS Revenue Proportion of Nuclear Medicine by Application in 2024
Table 65. SIEMENS Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 66. SIEMENS Recent Developments
Table 67. Lantheus Corporation Information
Table 68. Lantheus Description and Business Overview
Table 69. Lantheus Nuclear Medicine Product
Table 70. Lantheus Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Lantheus Revenue Proportion of Nuclear Medicine by Product in 2024
Table 72. Lantheus Revenue Proportion of Nuclear Medicine by Application in 2024
Table 73. Lantheus Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 74. Lantheus Recent Developments
Table 75. Bracco Imaging Corporation Information
Table 76. Bracco Imaging Description and Business Overview
Table 77. Bracco Imaging Nuclear Medicine Product
Table 78. Bracco Imaging Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Bracco Imaging Revenue Proportion of Nuclear Medicine by Product in 2024
Table 80. Bracco Imaging Revenue Proportion of Nuclear Medicine by Application in 2024
Table 81. Bracco Imaging Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 82. Bracco Imaging Recent Developments
Table 83. Bayer Corporation Information
Table 84. Bayer Description and Business Overview
Table 85. Bayer Nuclear Medicine Product
Table 86. Bayer Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Bayer Revenue Proportion of Nuclear Medicine by Product in 2024
Table 88. Bayer Revenue Proportion of Nuclear Medicine by Application in 2024
Table 89. Bayer Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 90. Bayer Recent Developments
Table 91. Eli Lilly Corporation Information
Table 92. Eli Lilly Description and Business Overview
Table 93. Eli Lilly Nuclear Medicine Product
Table 94. Eli Lilly Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Eli Lilly Revenue Proportion of Nuclear Medicine by Product in 2024
Table 96. Eli Lilly Revenue Proportion of Nuclear Medicine by Application in 2024
Table 97. Eli Lilly Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 98. Eli Lilly Recent Developments
Table 99. Aurobindo Pharma Corporation Information
Table 100. Aurobindo Pharma Description and Business Overview
Table 101. Aurobindo Pharma Nuclear Medicine Product
Table 102. Aurobindo Pharma Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Aurobindo Pharma Revenue Proportion of Nuclear Medicine by Product in 2024
Table 104. Aurobindo Pharma Revenue Proportion of Nuclear Medicine by Application in 2024
Table 105. Aurobindo Pharma Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 106. Aurobindo Pharma Recent Developments
Table 107. Mundipharma Corporation Information
Table 108. Mundipharma Description and Business Overview
Table 109. Mundipharma Nuclear Medicine Product
Table 110. Mundipharma Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Mundipharma Revenue Proportion of Nuclear Medicine by Product in 2024
Table 112. Mundipharma Revenue Proportion of Nuclear Medicine by Application in 2024
Table 113. Mundipharma Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 114. Mundipharma Recent Developments
Table 115. China Isotope & Radiation Corporation Information
Table 116. China Isotope & Radiation Description and Business Overview
Table 117. China Isotope & Radiation Nuclear Medicine Product
Table 118. China Isotope & Radiation Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. China Isotope & Radiation Revenue Proportion of Nuclear Medicine by Product in 2024
Table 120. China Isotope & Radiation Revenue Proportion of Nuclear Medicine by Application in 2024
Table 121. China Isotope & Radiation Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 122. China Isotope & Radiation Recent Developments
Table 123. Yantai Dongcheng Corporation Information
Table 124. Yantai Dongcheng Description and Business Overview
Table 125. Yantai Dongcheng Nuclear Medicine Product
Table 126. Yantai Dongcheng Nuclear Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Yantai Dongcheng Revenue Proportion of Nuclear Medicine by Product in 2024
Table 128. Yantai Dongcheng Revenue Proportion of Nuclear Medicine by Application in 2024
Table 129. Yantai Dongcheng Revenue Proportion of Nuclear Medicine by Geographic Area in 2024
Table 130. Yantai Dongcheng Recent Developments
Table 131. North America Nuclear Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 132. North America Nuclear Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 133. North America Nuclear Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 134. North America Nuclear Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 135. Asia-Pacific Nuclear Medicine Revenue by Region (2020-2025) & (US$ Million)
Table 136. Asia-Pacific Nuclear Medicine Revenue by Region (2026-2031) & (US$ Million)
Table 137. Asia-Pacific Nuclear Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 138. Asia-Pacific Nuclear Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 139. Europe Nuclear Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 140. Europe Nuclear Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 141. Europe Nuclear Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 142. Europe Nuclear Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 143. Latin America Nuclear Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 144. Latin America Nuclear Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 145. Latin America Nuclear Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 146. Latin America Nuclear Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 147. Middle East and Africa Nuclear Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 148. Middle East and Africa Nuclear Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 149. Middle East and Africa Nuclear Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 150. Middle East and Africa Nuclear Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 151. Nuclear Medicine Key Raw Materials, Industry Status and Trend
Table 152. Nuclear Medicine Key Raw Materials and Upstream Suppliers
Table 153. Nuclear Medicine Clients Status and Trend
Table 154. Nuclear Medicine Typical Clients
Table 155. Nuclear Medicine Distributors
Table 156. Nuclear Medicine Market Trends
Table 157. Nuclear Medicine Market Drivers
Table 158. Nuclear Medicine Market Challenges
Table 159. Nuclear Medicine Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Medicine Product Picture
Figure 2. Global Nuclear Medicine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Nuclear Medicine Revenue Market Share by Type in 2024 & 2031
Figure 4. Diagnostic Nuclear Medicine Product Picture
Figure 5. Therapeutic Nuclear Medicine Product Picture
Figure 6. Global Nuclear Medicine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Nuclear Medicine Revenue Market Share by Application in 2024 & 2031
Figure 8. Oncology
Figure 9. Thyroid
Figure 10. Cardiology
Figure 11. Others
Figure 12. Nuclear Medicine Report Years Considered
Figure 13. Global Nuclear Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Nuclear Medicine Market Size (2020-2031) & (US$ Million)
Figure 15. Global Nuclear Medicine Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Nuclear Medicine Revenue Market Share by Region (2020-2031)
Figure 17. Global Nuclear Medicine Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Nuclear Medicine Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Diagnostic Nuclear Medicine of Nuclear Medicine Revenue Market Share by Application, 2024 VS 2031
Figure 20. Therapeutic Nuclear Medicine of Nuclear Medicine Revenue Market Share by Application, 2024 VS 2031
Figure 21. Nuclear Medicine Revenue Share by Company (2024)
Figure 22. Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Diagnostic Nuclear Medicine Revenue Proportion by Company in 2024
Figure 24. Therapeutic Nuclear Medicine Revenue Proportion by Company in 2024
Figure 25. North America Nuclear Medicine Revenue 2020-2031 (US$ Million)
Figure 26. North America Nuclear Medicine Revenue Market Share by Type (2020-2025)
Figure 27. North America Nuclear Medicine Revenue Market Share by Application (2020-2025)
Figure 28. Asia-Pacific Nuclear Medicine Revenue 2020-2031 (US$ Million)
Figure 29. Asia-Pacific Nuclear Medicine Revenue Market Share by Region (2020-2031)
Figure 30. Asia-Pacific Nuclear Medicine Revenue Market Share by Type (2020-2025)
Figure 31. Asia-Pacific Nuclear Medicine Revenue Market Share by Application (2020-2025)
Figure 32. Europe Nuclear Medicine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 33. Europe Nuclear Medicine Revenue Market Share by Country (2020-2031)
Figure 34. Europe Nuclear Medicine Revenue Market Share by Type (2020-2025)
Figure 35. Europe Nuclear Medicine Revenue Market Share by Application (2020-2025)
Figure 36. Latin America Nuclear Medicine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Latin America Nuclear Medicine Revenue Market Share by Country (2020-2031)
Figure 38. Latin America Nuclear Medicine Revenue Market Share by Type (2020-2025)
Figure 39. Latin America Nuclear Medicine Revenue Market Share by Application (2020-2025)
Figure 40. Middle East and Africa Nuclear Medicine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Middle East and Africa Nuclear Medicine Revenue Market Share by Country (2020-2031)
Figure 42. Middle East and Africa Nuclear Medicine Revenue Market Share by Type (2020-2025)
Figure 43. Middle East and Africa Nuclear Medicine Revenue Market Share by Application (2020-2025)
Figure 44. Nuclear Medicine Supply Chain (Upstream and Downstream Market)
Figure 45. Global Production Market Share of Nuclear Medicine Raw Materials by Region in 2024
Figure 46. Nuclear Medicine Distribution Channels
Figure 47. Global Nuclear Medicine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 48. Global Nuclear Medicine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232